Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S van der Linden is active.

Publication


Featured researches published by S van der Linden.


Annals of the Rheumatic Diseases | 1989

Serum IgA, acute phase proteins, and glycosylation of alpha 1-acid glycoprotein in ankylosing spondylitis.

A Mackiewicz; M A Khan; T L Reynolds; S van der Linden; Irving Kushner

Several investigators have suggested that gastrointestinal inflammation has a role in the pathogenesis of ankylosing spondylitis. To test this hypothesis markers of gastrointestinal immunostimulation, as manifested by serum IgA concentrations, were compared with serum markers of inflammation, as manifested by acute phase proteins. Serum samples from 45 unrelated Caucasian patients with ankylosing spondylitis (AS) were tested for correlation of serum IgA and six acute phase proteins: C reactive protein (CRP), alpha 1-antitrypsin, alpha 1-antichymotrypsin, caeruloplasmin, alpha 1-acid glycoprotein (AGP), and haptoglobin. Serum IgA was shown to be significantly positively correlated with four of these six acute phase proteins: CRP (r = 0.58, p less than 0.001), alpha 1-antitrypsin (r = 0.29, p less than 0.05), AGP (r = 0.61, p less than 0.01), and haptoglobin (r = 0.58, p less than 0.001), suggesting that gastrointestinal immunostimulation does have a role in the pathogenesis of inflammation in AS. In addition, the microheterogeneity of the pattern of glycosylation of AGP, expressed as reactivity coefficients, was examined. The AGP reactivity coefficient has been shown to increase in infection, remain the same in systemic lupus erythematosus, and decrease in rheumatoid arthritis. It was found that the AGP reactivity coefficient was significantly decreased in patients with AS as compared with healthy controls (p less than 0.006). As recent studies have indicated that patterns of glycosylation reflect intrahepatocellular biosynthetic processes induced by cytokines our data suggest that cytokine-hepatocellular mechanisms in AS may be similar to those occurring in rheumatoid arthritis, but different from those in systemic lupus erythematosus or infection.


Annals of the Rheumatic Diseases | 1981

Leaking rheumatoid olecranon bursitis as a cause of forearm swelling.

J D Macfarlane; S van der Linden

A patient with seropositive rheumatoid arthritis and recurrent oedema of the forearm was shown to have a leak from a multilobulated olecranon bursa.


Annals of the Rheumatic Diseases | 2006

Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis

R. Landewé; P. Geusens; D. van der Heijde; Maarten Boers; S van der Linden; Patrick Garnero


Annals of the Rheumatic Diseases | 2006

Safety and patient satisfaction of infliximab administration in an extramural setting supervised by a rheumatology specialist nurse

Y. van Eijk; A. Boonen; G Schulpen; V Schrijnemaekers; H Fiolet; S van der Linden


Annals of the Rheumatic Diseases | 2002

Standing Committee on Epidemiology and Health Services Research

S van der Linden


Archive | 2007

Secondary osteoporosis in patients with a recent clinical fracture and low bone mineral density

Bianca Dumitrescu; S. van Helden; A. Nieuwenhuijzen-Kruseman; Caroline E. Wyers; G. Udrea; S van der Linden; Piet Geusens


Archive | 2006

arthritis and psoriasis? international working group: a model for psoriatic ASessment in Ankylosing Spondylitis (ASAS)

D. van der Heijde; J. Braun; John C. Davis; J. Sieper; S van der Linden


Archive | 2003

Serum levels of receptor activator of nuclear factor kappa-beta (RANK)-ligand (L) and osteoprotegerin (OPG) independently predict long-term radiographic progression in patients with early rheumatoid arthritis (RA)

Maarten Boers; S van der Linden; Patrick Garnero; R. Landewé; Piet Geusens; Désirée van der Heijde; Loes Linsen


Archive | 2002

Ankylosing spondylitis is a strong risk factor for vertebral fractures

Debby Vosse; S van der Linden; Piet Geusens; Johan Vanhoof


Archive | 2002

Receptor activator of the nuclear factor kappa-b ligand (RANKL) in the serum of patients with RA is strongly coupled to rheumatoid-factor presence, and predicts long-term radiologic progression.

Piet Geusens; R. Landewé; Colin R. Dunstan; P Gaenero; S van der Linden; Maarten Boers

Collaboration


Dive into the S van der Linden's collaboration.

Top Co-Authors

Avatar

Piet Geusens

Catholic University of Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maarten Boers

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. van der Heijde

Loyola University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Jef Raus

Transnational University Limburg

View shared research outputs
Top Co-Authors

Avatar

J. Braun

Ruhr University Bochum

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge